Kayano, Sotaro
Yanagisawa, Takafumi
Shibata, Ken
Nishi, Eriko
Yata, Yuji
Miyajima, Keiichiro
Fujisawa, Naoki
Yasuda, Yuka
Maiya, Shigetoshi
Shinozaki, Tetsuo
Yuen, Steffi Kar Kei
Simomura, Tatsuya
Kimura, Takahiro
Article History
Received: 6 October 2025
Accepted: 30 October 2025
First Online: 2 November 2025
Declarations
:
: Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. The other authors declare no conflicts of interest associated with this manuscript.
: This study was approved by the Ethics Committee of Ota Memorial Hospital (IRB approval number: OR 25009), which served as the central review board for both participating institutions, including IMS FUJIMI General Hospital. All procedures involving human participants were conducted in accordance with the ethical standards of the institutional review boards and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.